BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28531800)

  • 1. Restoration of Arpin suppresses aggressive phenotype of breast cancer cells.
    Li Y; Qiu J; Pang T; Guo Z; Su Y; Zeng Q; Zhang X
    Biomed Pharmacother; 2017 Aug; 92():116-121. PubMed ID: 28531800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways.
    Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J
    Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arpin downregulation in breast cancer is associated with poor prognosis.
    Lomakina ME; Lallemand F; Vacher S; Molinie N; Dang I; Cacheux W; Chipysheva TA; Ermilova VD; de Koning L; Dubois T; Bièche I; Alexandrova AY; Gautreau A
    Br J Cancer; 2016 Mar; 114(5):545-53. PubMed ID: 26867158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIPE2 suppresses the tumorigenesis, growth and metastasis of breast cancer via inhibition of the AKT and p38 signaling pathways.
    Zhang Z; Liu L; Liu C; Cao S; Zhu Y; Mei Q
    Oncol Rep; 2016 Dec; 36(6):3311-3316. PubMed ID: 27779698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
    Tan XL; Guo L; Wang GH
    Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
    Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
    Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
    Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
    Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells.
    Shen P; Wang HG; Li MM; Ma QY; Zhou CW; Pan F; Xie R
    Biomed Pharmacother; 2017 Aug; 92():78-85. PubMed ID: 28531803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells.
    Ma Y; Hao X; Zhang S; Zhang J
    Breast Cancer Res Treat; 2012 Jun; 133(2):473-85. PubMed ID: 21947651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
    Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
    Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
    Karam M; Legay C; Auclair C; Ricort JM
    Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression.
    Dai Y; Hogan S; Schmelz EM; Ju YH; Canning C; Zhou K
    Nutr Cancer; 2011; 63(5):795-801. PubMed ID: 21767082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.
    Li P; Zhang Q; Torossian A; Li ZB; Xu WC; Lu B; Fu S
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e391-7. PubMed ID: 22414288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J; Zeng J; Xin M; Huang W; Chen X
    Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
    Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
    Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.